“Rising Adoption of Iodine in Medical Imaging and Diagnostics”
- The use of iodine-based contrast agents is growing rapidly in radiology and nuclear medicine, owing to its high atomic number and superior X-ray attenuation properties
- The increasing global burden of chronic diseases such as cardiovascular disorders, cancer, and neurological conditions is accelerating the number of diagnostic procedures, boosting iodine demand
- Technological advances in non-invasive imaging and personalized healthcare are encouraging the integration of iodine-based agents in CT scans, angiography, and interventional radiology
- For instance, in February 2024, GE HealthCare announced the launch of a next-generation low-osmolar iodine contrast agent for enhanced safety in cardiovascular imaging
- This trend underscores the growing relevance of iodine in precision diagnostics and positions the healthcare sector as a major end-user driving innovation and volume growth
